By Vince Paolizzi
Published in: Pharmaceuticalonline
Published on: May 11, 2022
Introduction: Many companies have worked overtime to expand their ultra-cold chain operations, resulting in new challenges for their shipping operations, both in terms of scale and handling. These challenges extend to home collection shipping, particularly direct-from-patient tissue samples, which are becoming more common with the current surge in decentralized clinical trials (DCTs). The damage that can result from improper transport of these cells makes cold chain storage a crucial part of their handling.
